<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0585">
 <label>117</label>
 <mixed-citation publication-type="other" id="h0585">Sayad B, Sobhani M, Khodarahmi R. Sofosbuvir as repurposed antiviral drug against COVID-19: why were we convinced to evaluate the drug in a registered/approved clinical trial? Arch Med Res [Epub ahead of print] 2020. https://doi.org/10.1016/j.arcmed.2020.04.018.</mixed-citation>
</ref>
